期刊文献+

心脑血管中药复方专利发展进程及影响因素

Development process and influence factors of Chinese medicine compound prescription patent for cardiovascular and cerebrovascular disease
原文传递
导出
摘要 目的:研究心脑血管中药复方专利发展进程及影响因素。方法:将国家知识产权局专利数据库、中国专利信息中心及相关事务所作为专利数据来源;以万方数据库、CNKI、CHKD数据库作为科研成果检索资源;运用简单统计与聚类分析的方法,把年度数据当作聚类成员,以心脑血管中药复方专利申请量、公开量、科研成果作为聚类变量,对20年来心脑血管中药复方专利展开聚类分析。结果:心脑血管中药复方专利在20年的时间里经历了3个阶段:1991至2000年是第一阶段,专利申请量、公开量、科研论文数量较低;第二阶段为2001至2004年,专利申请量、公开量是第一阶段的2倍,而科研论文数是第一阶段的3倍;第三阶段是2005年至2010年,3个指标均为第二阶段的2倍。结论:心脑血管中药复方专利的发展与国家政策、专利制度、中医药科研等因素密切相关。 Objective: To study the development process and influence factors of Chinese medicine compound prescription patent for cardiovascular and cerebrovascular disease. Methods: Patent database of the State Intellectual Property Office, China Patent Information Center and related firms were used as the data sources, while the search tools of scientific achievements were the Wanfang database, CNKI database, CHKD database and so on. With the simple statistics and cluster analysis methods, taking the annual data as cluster members, the application amount, open volume and scientific achievements of cardiovascular and cerebrovascular medicine compound patent putting as clustering variables, the clustering analysis was conducted to cardiovascular and cerebrovascular medicine compound patent for the last twenty years. Results: Chinese herbal compound patents in treating cardiovascular and cerebrovascular disease had gone through three stages in the last twenty years: The first stage was from 1991 to 2000, the amount of patent application and maintenance dose, the number of research papers were low; the second stage was from 2001 to 2004, the number of patent applications, the maintain dose was twice of the first stage, and the number of research papers was three times as many as the first stage; the third stage was from 2005 to 2010, the three indicators were two times that of the second stage. Conclusion: The development of Chinese herbal compound patents in treating cardiovascular and cerebrovascular disease is closely related to national policy, patent system, scientific research of traditional Chinese medicine and other factors.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2016年第10期4266-4270,共5页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 河北省教育厅基金项目(No.QN20131073)~~
关键词 心脑血管 中药复方 专利 年度发展 聚类分析 Cardiovascular and cerebrovascular Compound prescription of TCM Patent Annual development Cluster analysis
  • 相关文献

参考文献20

  • 1吴小平,刘放.抗血小板聚集药物研究进展[J].西北药学杂志,2009,24(4):327-330. 被引量:20
  • 2Zhang H,Liu M L.US prevents,the examination,appraised and treats the hypertension joint board seventh report.Jam Med Assoc:Chin Ed,2013,22(55):242-247. 被引量:1
  • 3Gao Z, Guo R L.Reduces 80% about cardiovascular disease the treatment strategy.BMJ:Chin Ed,2014,7(1):19-23. 被引量:1
  • 4罗万玲,李宝才.中药治疗心血管病研究现状[J].中西医结合心脑血管病杂志,2006,4(6):514-517. 被引量:5
  • 5马培奇.全球主要治疗领域市场现状及其未来重要药物.全国医药商情,2007,3:33-38. 被引量:1
  • 6Smdipto G,Rajeev R,Kyuseok S.CURE:An Efficient Clustering Algorithm of Large Database.Proe of the ACM SIGMOD International Conference on Man_agement of Data.New York:ACM Press,2008. 被引量:1
  • 7Matin E,Hans-P K,Xiao wei X,et al.A Density-based Algorithm for Discovering Clusters in Large Spatial Da.tabases.Proe of the International Conference on Knowledge Discovery and Data Mining.Portland:AAAI Press,2006. 被引量:1
  • 8Tseng Y,Lin H.Text mining techniques for patent analysis. Information Processing and Management,2015,43:12-16. 被引量:1
  • 9陈燕,黄迎燕,方建国,等.专利信息采集与分析.北京:清华大学出版社,.2006:6-64. 被引量:13
  • 10王敏,李海存,许培扬.国外专利文本挖掘可视化工具研究[J].图书情报工作,2009,53(24):86-90. 被引量:30

二级参考文献201

共引文献132

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部